Recursion Pharma is combining high-throughput experimental biology, bioinformatics, and machine learning to rapidly identify new indications for many known drugs and shelved assets. The company completed its IPO [NASDAQ: RXRX] in 2021.
Recursion Pharma is a Salt Lake City-based drug discovery company founded in 2013 based on technology developed at the University of Utah. Recursion uses a novel drug screening platform to efficiently reposition known drugs and shelved pharmaceutical assets to treat rare genetic diseases and other conditions.
- Chris Gibson, PhD
- Blake Borgeson, PhD
- Dean Li, PhD
- We’re hiring! Recursion is seeking a Director of Business Process Management to design and execute processes that w… https://t.co/BAzdltH21D
- Recursion’s Innovation and Scale Up Team is hiring a Process Development Research Scientist. This role will support… https://t.co/XODeZvilij
- Recursion is seeking an experienced Medical Writer to join our growing team. This role will support our Clinical Op… https://t.co/nZrWJb54Mn